Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 2138-2148

  Pang, Maoyin ^a   Ma, Li ^a   Liu, Na ^a,b   Ponnusamy, Murugavel ^a   Zhao, Ting C ^c   Yan, Haidong ^b   Zhuang, Shougang ^a,b  

^a BROWN UNIVERSITY   (United States)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Histone deacetylase; Proliferation; Renal interstitial fibroblasts; Signal transducer and activator of transcription 3; Trichostatin A

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; PROTEIN P27; PROTEIN P57; SMALL INTERFERING RNA; STAT3 PROTEIN; TRICHOSTATIN A;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; GENE SILENCING; KIDNEY INTERSTITIAL FIBROBLAST; KIDNEY INTERSTITIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; KIDNEY; MICE; MICE, KNOCKOUT; RATS; STAT3 TRANSCRIPTION FACTOR;

RATTUS;

EID: 79960383466     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23135     Document Type: Article

References (31)

1. Alao JP, Lam EW, Ali S, Buluwela L, Bordogna W, Lockey P, Varshochi R, Stavropoulou AV, Coombes RC, Vigushin DM,. 2004. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. Clin Cancer Res 10: 8094-8104. (Pubitemid 39587551)
2. Alao JP, Stavropoulou AV, Lam EW, Coombes RC, Vigushin DM,. 2006. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Mol Cancer 5: 8.
3. Beumer JH, Tawbi H,. 2010. Role of histone deacetylases and their inhibitors in cancer biology and treatment. Curr Clin Pharmacol 5: 196-208.
4. Bieliauskas AV, Pflum MK,. 2008. Isoform-selective histone deacetylase inhibitors. Chem Soc Rev 37: 1402-1413.
5. Bowman T, Garcia R, Turkson J, Jove R,. 2000. STATs in oncogenesis. Oncogene 19: 2474-2488. (Pubitemid 30339203)
6. Chen JS, Faller DV,. 2005. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. J Cell Physiol 202: 87-99. (Pubitemid 39603365)
7. Deelman L, Sharma K,. 2009. Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens 18: 85-90.
8. Freidkin I, Herman M, Tobar A, Chagnac A, Ori Y, Korzets A, Gafter U,. 2010. Effects of histone deacetylase inhibitors on rat mesangial cells. Am J Physiol Renal Physiol 298: F426-F434.
9. Freytag SO, Geddes TJ,. 1992. Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Science 256: 379-382.
10. Golias CH, Charalabopoulos A, Charalabopoulos K,. 2004. Cell proliferation and cell cycle control: A mini review. Int J Clin Pract 58: 1134-1141. (Pubitemid 40123748)
11. Hengst L, Reed SI,. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861-1864.
12. Hinkle CL, Sunnarborg SW, Loiselle D, Parker CE, Stevenson M, Russell WE, Lee DC,. 2004. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: The juxtamembrane stalk determines cleavage efficiency. J Biol Chem 279: 24179-24188. (Pubitemid 38725278)
13. Hu J, Colburn NH,. 2005. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Mol Cancer Res 3: 100-109. (Pubitemid 40271140)
14. Klampfer L, Huang J, Swaby LA, Augenlicht L,. 2004. Requirement of histone deacetylase activity for signaling by STAT1. J Biol Chem 279: 30358-30368. (Pubitemid 38937963)
15. Kramer OH, Knauer SK, Greiner G, Jandt E, Reichardt S, Guhrs KH, Stauber RH, Bohmer FD, Heinzel T,. 2009. A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev 23: 223-235.
16. Lee KW, Kim JH, Park JH, Kim HP, Song SH, Kim SG, Kim TY, Jong HS, Jung KH, Im SA, Kim TY, Kim NK, Bang YJ,. 2006. Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells. Anticancer Res 26: 3429-3438. (Pubitemid 44701519)
17. Mai A, Massa S, Rotili D, Cerbara I, Valente S, Pezzi R, Simeoni S, Ragno R,. 2005. Histone deacetylation in epigenetics: An attractive target for anticancer therapy. Med Res Rev 25: 261-309. (Pubitemid 40489663)
18. Monneret C,. 2005. Histone deacetylase inhibitors. Eur J Med Chem 40: 1-13. (Pubitemid 40092373)
19. Nusinzon I, Horvath CM,. 2003. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc Natl Acad Sci USA 100: 14742-14747. (Pubitemid 37517961)
20. Pang M, Kothapally J, Mao H, Tolbert E, Ponnusamy M, Chin YE, Zhuang S,. 2009. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 297: F996-F1005.
21. Pang M, Ma L, Gong R, Tolbert E, Mao H, Ponnusamy M, Chin YE, Yan H, Dworkin LD, Zhuang S,. 2010. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int 78: 257-268.
22. Rossi G, Viola Magni M, Albi E,. 2007. Signal transducer and activator of transcription 3 and sphingomyelin metabolism in intranuclear complex during cell proliferation. Arch Biochem Biophys 464: 138-143. (Pubitemid 47088365)
23. Shirane M, Harumiya Y, Ishida N, Hirai A, Miyamoto C, Hatakeyama S, Nakayama K, Kitagawa M,. 1999. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274: 13886-13893. (Pubitemid 129518688)
24. Song JI, Grandis JR,. 2000. STAT signaling in head and neck cancer. Oncogene 19: 2489-2495. (Pubitemid 30339204)
25. Vlach J, Hennecke S, Amati B,. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. Embo J 16: 5334-5344. (Pubitemid 27380141)
26. Wynn TA,. 2008. Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210. (Pubitemid 351160157)
27. Xing J, Zhang Z, Mao H, Schnellmann RG, Zhuang S,. 2008. Src regulates cell cycle protein expression and renal epithelial cell proliferation via PI3K/Akt signaling-dependent and -independent mechanisms. Am J Physiol Renal Physiol 295: F145-F152.
28. Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C, Matthias P,. 2010. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev 24: 455-469.
29. Yuan ZL, Guan YJ, Chatterjee D, Chin YE,. 2005. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307: 269-273. (Pubitemid 40116244)
30. Zimmermann S, Kiefer F, Prudenziati M, Spiller C, Hansen J, Floss T, Wurst W, Minucci S, Gottlicher M,. 2007. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res 67: 9047-9054. (Pubitemid 47535889)
31. Zupkovitz G, Tischler J, Posch M, Sadzak I, Ramsauer K, Egger G, Grausenburger R, Schweifer N, Chiocca S, Decker T, Seiser C,. 2006. Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol Cell Biol 26: 7913-7928. (Pubitemid 44630992)